Breaking News
Get 45% Off 0
Trade war-resistant stocks: Our screener found these winners
See Stocks
Close

Manulife Retirementplus Ci Cdn Asset Alloc (0P00010MAS)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
14.846 +0.116    +0.78%
19/03 - Closed. Currency in CAD
Type:  Fund
Market:  Canada
Issuer:  Manufacturers Life Insurance Co
Asset Class:  Other
  • Morningstar Rating:
  • Total Assets: 19.79M
Manulife RetirementPlus CI Cambridge Cdn Asset All 14.846 +0.116 +0.78%

0P00010MAS Historical Data

 
Get free historical data for 0P00010MAS fund. You'll find the end of day price of the Manulife Retirementplus Ci Cdn Asset Alloc fund for the selected range of dates. The data can be viewed in daily, weekly or monthly time intervals. At the bottom of the table you'll find the data summary for the selected range of dates.
Time Frame:
02/20/2025 - 03/20/2025
 
Date Price Open High Low Change %
Mar 19, 2025 14.846 14.846 14.846 14.846 0.78%
Mar 18, 2025 14.730 14.730 14.730 14.730 -0.26%
Mar 17, 2025 14.768 14.768 14.768 14.768 0.41%
Mar 14, 2025 14.707 14.707 14.707 14.707 0.83%
Mar 13, 2025 14.586 14.586 14.586 14.586 -0.73%
Mar 12, 2025 14.693 14.693 14.693 14.693 0.05%
Mar 11, 2025 14.685 14.685 14.685 14.685 -0.54%
Mar 10, 2025 14.765 14.765 14.765 14.765 -0.72%
Mar 06, 2025 14.872 14.872 14.872 14.872 -1.12%
Mar 05, 2025 15.040 15.040 15.040 15.040 0.25%
Mar 04, 2025 15.002 15.002 15.002 15.002 -1.13%
Mar 03, 2025 15.173 15.173 15.173 15.173 -0.95%
Feb 28, 2025 15.318 15.318 15.318 15.318 0.82%
Feb 27, 2025 15.194 15.194 15.194 15.194 -0.37%
Feb 26, 2025 15.250 15.250 15.250 15.250 0.17%
Feb 25, 2025 15.225 15.225 15.225 15.225 0.49%
Feb 24, 2025 15.150 15.150 15.150 15.150 0.03%
Feb 21, 2025 15.146 15.146 15.146 15.146 -0.40%
Feb 20, 2025 15.207 15.207 15.207 15.207 -0.82%
Highest: 15.318 Lowest: 14.586 Difference: 0.732 Average: 14.966 Change %: -3.177
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0P00010MAS Comments

Write your thoughts about Manulife Retirementplus Ci Cdn Asset Alloc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email